After previous disappointments with BTK inhibitors, a novel drug in this class is the first to show superiority to an active comparator for relapsing MS outcomes.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/first-clear-win-btk-inhibitors-relapsing-ms-2026a1000ieg?src=rss
Author :
Publish date : 2026-06-02 21:25:00
Copyright for syndicated content belongs to the linked Source.